The majority of cervical squamous cell carcinomas (CSCCs) are associated with human papillomaviruses infection and develop from precursor lesions of the squamous cervical epithelium (SCE). Precursor lesions of the SCE are divided into low-grade squamous intraepithelial lesions (LSILs) and high-grade squamous intraepithelial lesions (HSILs). HSILs may be further subdivided into HSIL/cervical intraepithelial neoplasia (CIN), grade 2 (CIN 2) and HSIL/CIN, grade 3 (CIN 3). Recent studies on CSCC have suggested that tumorigenesis depends on cancer stem cells (CSCs). CSCs express several markers, NANOG, OCT3/4, and SOX2 among the others. We analysed expression and diagnostic significance of NANOG and its regulation on protein, RNA and DNA levels in cervical squamous carcinogenesis.
Our study included 40 biopsy tissue samples from patients with CSCCs and SILs/CINs and their adjacent non-dysplastic SCE. Immunohistochemistry, HPV genotyping, quantitative polymerase chain reaction and Sanger sequencing were used.
NANOG and SOX2 immunohistochemical expression gradually increased from non-dysplastic SCE via LSIL and HSIL to CSCC. HPV infection was confirmed in all 40 included patients. At mRNA level, NANOG was maximally expressed in CSCCs. Regulators OCT3/4 and RoR correlated positively with expression of NANOG, while miR-145 was negatively correlated with expression of NANOG. NANOG promoter methylation was not changed.
Our results showed higher expression of proteins NANOG and SOX2 in LSIL compared to nondysplastic SCE and lower compared to HSIL. HSIL/CIN 3 showed higher immunohistochemical expression of SOX2 than HSIL/CIN 2. The expression of NANOG mRNA was different from the expression of NANOG protein, indicating an important role of post-transcription regulation, with miR-145 and RoR as the key regulatory mechanisms beside protein regulators in cervical squamous carcinogenesis. Our results contributed new insights into the role of NANOG regulators in the cervical squamous carcinogenesis. We also confirmed a potential of NANOG and SOX2 as additional diagnostic markers for classifying SILs/CINs.
|